Weekly injections of the GLP-1 semaglutide reduce alcohol consumption in patients with obesity seeking treatment for alcohol ...
The study found that the active ingredient in GLP-1 drugs "significantly improved" motivation in patients with major ...
Once-weekly semaglutide was tied to a reduction in heavy drinking days among adults with obesity and alcohol use disorder, ...
A recent study finds that the active ingredient in Wegovy and Ozempic significantly decreased heavy drinking in patients with ...
GLP-1 drugs tirzepatide and semaglutide may offer increased protection against heart attack, stroke and death from any cause, according to a November study published in Nature Medicine and presented ...
In a phase III trial, orforglipron yielded better HbA1c reduction compared with oral semaglutide at 52 weeks. Gastrointestinal side effects were more common with orforglipron, leading to more ...
How Compounded Semaglutide, Compounded Tirzepatide, and GLP-1 Telehealth Prescription Weight Loss Programs Work for Eligible ...
Treatment with oral semaglutide (Rybelsus) significantly improved motivation measures in patients with major depressive ...
As weight‑loss drugs surge in popularity, a study raises a new question about what patients may be losing along the way.
Patients on semaglutide who experienced constipation had greater weight loss than those without constipation, and genes could be at play.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results